Investigation of tolerability and quality of life for carboplatin-based chemotherapy in an elderly urothelial carcinoma patient undergoing hemodialysis: a case report

BACKGROUND: To our knowledge, no studies have evaluated the safety of carboplatin (CBDCA)-based chemotherapy in hemodialysis patients > 80 years-old. In addition, the impact of CBDCA-based chemotherapy on such elderly patients’ quality of life (QOL) is unknown. We report a case of gemcitabine plu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kondo, Masahiro, Naiki, Taku, Hotta, Yuji, Yamamoto, Yuko, Sugiyama, Yosuke, Yasui, Takahiro, Kimura, Kazunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264041/
https://www.ncbi.nlm.nih.gov/pubmed/30519478
http://dx.doi.org/10.1186/s40780-018-0124-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264041/
https://www.ncbi.nlm.nih.gov/pubmed/30519478
http://dx.doi.org/10.1186/s40780-018-0124-0

Ejemplares similares